MRP Capital Investments LLC Takes Position in Astera Labs, Inc. $ALAB

MRP Capital Investments LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,515 shares of the company’s stock, valued at approximately $318,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Alliancebernstein L.P. increased its stake in shares of Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock valued at $501,289,000 after purchasing an additional 4,478,741 shares during the period. Atreides Management LP boosted its position in shares of Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after buying an additional 2,815,614 shares during the period. Vanguard Group Inc. grew its holdings in Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after buying an additional 2,751,747 shares in the last quarter. FengHe Fund Management Pte. Ltd. acquired a new stake in Astera Labs in the 2nd quarter valued at approximately $106,772,000. Finally, 1832 Asset Management L.P. increased its position in Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after acquiring an additional 929,600 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Trading Down 14.3%

NASDAQ:ALAB opened at $148.85 on Friday. The company has a 50-day moving average of $166.62 and a 200-day moving average of $153.61. The firm has a market cap of $25.14 billion, a price-to-earnings ratio of 134.10, a price-to-earnings-growth ratio of 2.77 and a beta of 1.51. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business’s revenue for the quarter was up 103.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on ALAB shares. Citigroup reissued an “outperform” rating on shares of Astera Labs in a research note on Tuesday. TD Cowen reduced their price objective on shares of Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a report on Wednesday, November 5th. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Bank of America began coverage on shares of Astera Labs in a research note on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price target for the company. Finally, Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $188.17.

Insider Activity at Astera Labs

In other news, CFO Michael Truett Tate sold 11,430 shares of the firm’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the completion of the sale, the chief financial officer directly owned 192,297 shares of the company’s stock, valued at $27,823,452.93. This trade represents a 5.61% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares in the company, valued at $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 586,936 shares of company stock worth $89,331,140. 12.50% of the stock is owned by corporate insiders.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.